Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Cauley, J. A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Effects of Thiazide Diuretic Therapy on Bone Mass, Fractures, and Falls

right arrow Jane A. Cauley; Steven R. Cummings; Dana G. Seeley; Dennis Black; Warren Browner; Lewis H. Kuller; Michael C. Nevitt, For the Study of Osteoporotic Fractures Research Group*

1 May 1993 | Volume 118 Issue 9 | Pages 666-673

Objective: To determine the relation between the use of thiazide diuretics and bone mass, fractures, and falls in older women.

Design: Cross-sectional study of thiazide diuretics, bone mass, and prevalent vertebral deformities; cohort analysis of thiazide diuretics and nonspinal fractures and falls.

Setting: Four clinical centers located in Baltimore, Maryland; Minneapolis, Minnesota; Portland, Oregon; and the Monongahela Valley, Pennsylvania.

Participants: A total of 9704 ambulatory, nonblack women who were 65 years or older.

Measurements: Information on thiazide use, demographic data, medical history, and anthropometric measurements were obtained by questionnaire, interview, and examination. Appendicular bone mass was measured by single-photon absorptiometry. Incident falls and fractures were ascertained every 4 months.

Results: Women using thiazide diuretics for more than 10 years had significantly higher bone mass than women who had never used thiazide diuretics (for example, 0.381 g/cm2 compared with 0.355 g/cm2 for the distal radius [P < 0.001]). Current users of thiazide diuretics had an incidence of falls (relative risk, 1.06; 95% CI, 0.90 to 1.25) that was similar to that of those who had never used these drugs. After adjusting for age, body weight, functional status, total calcium intake, duration of estrogen replacement therapy, and self-reported health status, we found that current users of thiazide diuretics who had taken these drugs for more than 10 years had a risk for nonspinal (relative risk, 0.99; CI, 0.81 to 1.20) and osteoporotic (relative risk, 0.98; CI, 0.79 to 1.22) fractures that was similar to that of women who had never used thiazides; however, thiazide users did have a lower risk for fractures of the hip (relative risk, 0.63; CI, 0.34 to 1.16) and wrist (relative risk, 0.66; CI, 0.40 to 1.08), neither of which was significant.

Conclusions: Thiazide diuretics have no effect on a woman's risk for falling or for experiencing nonspinal fractures. The trend toward a lower risk for hip and wrist fractures is consistent with findings in previous cohort studies but may reflect selection factors for the use of thiazide diuretics. A randomized trial is needed to determine the effect of thiazide diuretics on the incidence of fractures.

From the University of Pittsburgh, Pittsburgh, Pennsylvania; the University of California, San Francisco, California.

*Members and participating institutions are listed in the Appendix. For current author addresses, see end of text.


Related articles in Annals:

Articles
Factors Associated with Appendicular Bone Mass in Older Women
Douglas C. Bauer, Warren S. Browner, Jane A. Cauley, Eric S. Orwoll, Jean C. Scott, Dennis M. Black, Jo L. Tao, Steven R. Cummings, AND Study of Osteoporotic Fractures Research Group*
Annals 1993 118: 657-665. [ABSTRACT][Full Text]  

Editorials
Risk Factors for Low Bone Mass: Clinical Implications
Charles W. Slemenda
Annals 1993 118: 741-742. [Full Text]  



This article has been cited by other articles:


Home page
Arch Intern MedHome page
R. E. Scranton, E. Lawler, M. Young, and J. M. Gaziano
Statins and Fracture: Are All Variables Accounted For?--Reply
Arch Intern Med, May 8, 2006; 166(9): 1041 - 1042.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
R. E. Scranton, M. Young, E. Lawler, D. Solomon, D. Gagnon, and J. M. Gaziano
Statin Use and Fracture Risk: Study of a US Veterans Population
Arch Intern Med, September 26, 2005; 165(17): 2007 - 2012.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
G. Miltiadous, D. P. Mikhailidis, and M. Elisaf
Acid-Base and Electrolyte Abnormalities Observed in Patients Receiving Cardiovascular Drugs
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2003; 8(4): 267 - 276.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
M. W.C.J. Schoofs, M. van der Klift, A. Hofman, C. E.D.H. de Laet, R. M.C. Herings, T. Stijnen, H. A.P. Pols, and B. H.Ch. Stricker
Thiazide Diuretics and the Risk for Hip Fracture
Ann Intern Med, September 16, 2003; 139(6): 476 - 482.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D. G Hackam and J. S Ashcroft
Drug treatment of hypertension
BMJ, April 5, 2003; 326(7392): 764 - 764.
[Full Text]


Home page
Nephrol Dial TransplantHome page
D. N. Cruz
The renal tubular Na-Cl co-transporter (NCCT): a potential genetic link between blood pressure and bone density?
Nephrol. Dial. Transplant., April 1, 2001; 16(4): 691 - 694.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. Z. LaCroix, S. M. Ott, L. Ichikawa, D. Scholes, and W. E. Barlow
Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
Ann Intern Med, October 3, 2000; 133(7): 516 - 526.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. S. Adams, C. F. Song, and V. Kantorovich
Rapid Recovery of Bone Mass in Hypercalciuric, Osteoporotic Men Treated with Hydrochlorothiazide
Ann Intern Med, April 20, 1999; 130(8): 658 - 660.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Moghetti, R. Castello, N. Zamberlan, M. Rossini, D. Gatti, C. Negri, F. Tosi, M. Muggeo, and S. Adami
Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1250 - 1254.
[Abstract] [Full Text]


Home page
JWatch Women's HealthHome page
Osteoporosis: New Treatment Strategies
Journal Watch Women's Health, March 1, 1997; 1997(301): 21 - 21.
[Full Text]


Home page
NEJMHome page
J. A. Grisso, J. L. Kelsey, B. L. Strom, L. A. O'Brien, G. Maislin, K. LaPann, L. Samelson, S. Hoffman, and Northeast Hip Fracture Study Group
Risk Factors for Hip Fracture in Black Women
N. Engl. J. Med., June 2, 1994; 330(22): 1555 - 1559.
[Abstract] [Full Text]


Home page
JWatch GeneralHome page
DETERMINANTS OF BONE MASS IN OLDER WOMEN
Journal Watch (General), May 18, 1993; 1993(518): 2 - 2.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1993 by the American College of Physicians.